Heterogeneity of Adenosine Triphosphate-Based Chemotherapy Response Assay in Colorectal Cancer - Secondary Publication

키워드

참고문헌 (35)

1. Parkin DM, "Global cancer statistics, 2002", CA Cancer J Clin, 55, pp.74~108 (2005)
2. Goldberg RM, "Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection, in Eastern Cooperative Oncology Group, the North Central Center Treatment Gtoup, and the Southwest Oncology Group", Ann Intern Med, 129, pp.27~35 (1998)
3. Liefers GJ, "Cancer genetics and their application to individualised medicine", Eur J Cancer, 38, pp.872~879 (2002)
4. Cortazar P, "Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer", J Clin Oncol, 17, pp.1625~1631 (1999)
5. Bogden AE, "Predictive testing with the subrenal capsule assay", Cancer Treat Rev, 11(A), pp.113~124 (1984)
6. Rozencweig M, "In vitro growth of human malignancies in a cloning assay", Recent Results Cancer Res, 94, pp.1~7 (1984)
7. Tanigawa N, "Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture", Cancer Res, 42, pp.2159~2164 (1982)
8. Yamaue H, "Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay", Eur J Cancer, 27, pp.1258~1263 (1991)
9. Vescio RA, "In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture", Proc Natl Acad Sci U S A, 통권 : 84, pp.5029~5033 (1987)
10. Sevin BU, "Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing", Gynecol Oncol, 31, pp.191~204 (1988)
11. Petty RD, "Comparison of MTT and ATP-based assays for the measurement of viable cell number", J Biolumin Chemilumin, 10, pp.29~34 (1995)
12. Cree IA, "Heterogeneity of chemosensitivity of metastatic cutaneous melanoma", Anticancer Drugs, 10, pp.437~444 (1999)
13. Cree IA, "Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity", Anticancer Drugs, 7, pp.630~635 (1996)
14. Kawamura H, "The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer", Eur J Cancer, 33, pp.960~966 (1997)
15. Konecny G, "Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer", Gynecol Oncol, 77, pp.258~263 (2000)
16. Shin Myung Kang, "A Feasibility Study of Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA) as a Chemosensitivity Test for Lung Cancer", Cancer Research and Treatment, 37(4), pp.223~227 (2005), 대한암학회
17. Whitehouse PA, "Portsmouth Colorectal Cancer Multidisci- plinary Team, in Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA)", Anticancer Drugs, 14, pp.369~375 (2003)
18. 허정욱, "대장암에서 Adenosine Triphosphate Based Chemotherapy Response Assay (ATP-CRA)를 이용한 In Vitro 항암제 감수성 검사", Journal of the Korean Society of Coloproctolgy, 23(3), pp.172~177 (2007), 대한대장항문학회
19. 허정욱, "Complete Remission of Unresectable Colon Cancer after Preoperative Chemotherapy Selected by Adenosine Triphosphate-Based Chemotherapy Response Assay", Journal of Korean Medical Science, 23(5), pp.916~919 (2008), 대한의학회
20. Weisenthal LM, "Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms", Cancer Treat Rep, 70, pp.1283~1295 (1986)
21. Bird MC, "In vitro determination of tumour chemosensitivity in haematological malignancies", Hematol Oncol, 3, pp.1~10 (1985)
22. Nakahara T, "Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas", Pharm Res, 21, pp.406~412 (2004)
23. Swanton C, "Chromosomal instability, colorectal cancer and taxane resistance", Cell Cycle, 5, pp.818~823 (2006)
24. Furukawa T, "Clinical applications of the histoculture drug response assay", Clin Cancer Res, 1, pp.305~311 (1995)
25. Maehara Y, "Tumor tissue is more sensitive to mitomycin C, carboquone, and aclacinomycin A than is adjacent normal tissue in vitro", J Surg Oncol, 40, pp.4~7 (1989)
26. Reinhold U, "Chemosensitivity testing in oncology", pp.108~145 (2003), Springer-Verlag
27. Kodera Y, "In vitro chemosensitivity for paclitaxel, using human gastric carcinoma tissues", Int J Clin Oncol, 11, pp.449~453 (2006)
28. Iwahashi M, "Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer", Anticancer Res, 25, pp.3453~3459 (2005)
29. Samson DJ, "Chemotherapy sensitivity and resistance assays: a systematic review", J Clin Oncol, 22, pp.3618~3630 (2004)
30. Schrag D, "ASCO Working Group on Chemotherapy Sensitivity and Resistance Assays. American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays", J Clin Oncol, 22, pp.3631~3638 (2004)
31. Neale MH, "Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside", Br J Cancer, 79, pp.1487~1493 (1999)
32. Ng TY, "Clinical applicability of the ATP cell viability assay as a predictor of chemoresponce in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples", Gynecol Oncol, 76, pp.405~408 (2000)
33. Moon YW, "Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer", Cancer, 109, pp.1829~1835 (2007)
34. Goldberg RM, "A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer", J Clin Oncol, 22, pp.23~30 (2004)
35. Tournigand C, "FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study", J Clin Oncol, 22, pp.229~237 (2004)

관련 논문AI추천